When treating patients with immune checkpoint inhibitors, do you routinely check markers of endocrinopathies such as TSH/ACTH, or only when a patient has symptoms?

1 Answers

Mednet Member

Medical Oncology · The Ohio State University School of Medicine

There are clearly defined parameters for routine monitoring that are outlined in the NCCN guidelines. We have incorporated these into our treatment plans.

https://www.nccn.org/professionals/physician_gls/pdf/immunotherapy.pdf

When treating patients with immune checkpoint inhibitors, do you routinely check markers of endocrinopathies such as TSH/ACTH, or only when a patient has symptoms? | Mednet